Envoy Medical Inc (COCH) Stock Price, Quote & News

Company Profile

Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy...

Industry: Medical Devices

Sector: Healthcare

Phone: 877 900 3277

Website: www.envoymedical.com

Address:

4875 White Bear Parkway, White Bear Lake, United States

AllHailTrump2024 Oct. 28 at 2:03 PM

$COCH

0 · Reply

AllHailTrump2024 Oct. 27 at 8:28 PM

$COCH TRUMP back in baby. 8000 shares with a .8225 average and 4 limit buy orders pending. There is big news coming and it’s gonna make it rise RISE I say.

0 · Reply

VishalMathew Oct. 27 at 5:56 PM

$COCH Note that public warrants(COCHW) are exercisable only at 11.5 $. Unregistered warrants are exercisable at 1.3$

0 · Reply

newsfile_corp Oct. 27 at 12:01 PM

https://nfne.ws/272006 $COCH @envoymedical #Chemicals #Biotechnology #HealthCare #NASDAQ #Investing

0 · Reply

Wintermelonjuice Oct. 26 at 8:18 PM

$COCH guess co has some catalysts to support warrant conversion at $1.30. Earnings coming in around Nov 14 based on last year.

2 · Reply

BinaryLogic Oct. 25 at 7:55 PM

$COCH The 10/07 Doji stands out like a sore thumb, as the Company decided to dilute literally the day following 100-200% spike from $0.75 that I specifically mentioned to the board 1-2wks prior (below). Well-the Company remains a strong small bio consideration (IMO), consolidating at the $0.75-0.85 support range that I mentioned previously, now with a stronger balance sheet. Note: all placements have been made with $1.30 strike, so investors here are purchasing/acquiring at a sizeable discount. DCA at/around $0.8 with 50-100% upside (IMO) near/intermediate term.

0 · Reply

Wintermelonjuice Oct. 25 at 4:43 PM

$COCH number of sponsors is growing?

1 · Reply

VicAge Oct. 24 at 7:41 PM

$COCH time for insiders to step up and buy shares to show confidence in the path forward.

0 · Reply

DaarT5903 Oct. 24 at 3:39 PM

$COCH $1.90 please lol

0 · Reply

Wintermelonjuice Oct. 23 at 2:09 PM

$COCH needs clarity on how the trial will be fully funded

2 · Reply

Envoy Medical Receives Positive Listing Determination from NASDAQ

Oct 9, 2025, 4:05 PM EDT - 19 days ago

Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 8, 2025, 7:00 AM EDT - 20 days ago

Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 7, 2025, 8:00 AM EDT - 21 days ago

Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Oct 7, 2025, 8:00 AM EDT - 21 days ago

Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Oct 1, 2025, 8:00 AM EDT - 27 days ago

Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th

Sep 25, 2025, 8:00 AM EDT - 4 weeks ago

Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 24, 2025, 8:00 AM EDT - 4 weeks ago

Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track

Sep 22, 2025, 8:00 AM EDT - 5 weeks ago

Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 19, 2025, 8:00 AM EDT - 5 weeks ago

Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology

Sep 10, 2025, 8:00 AM EDT - 6 weeks ago

Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments

Sep 9, 2025, 8:00 AM EDT - 7 weeks ago

Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology

Sep 8, 2025, 8:00 AM EDT - 7 weeks ago

Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025

Sep 3, 2025, 8:00 AM EDT - 7 weeks ago

Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant

Aug 26, 2025, 8:00 AM EDT - 2 months ago

Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board

Aug 20, 2025, 8:00 AM EDT - 2 months ago

Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology

Jul 31, 2025, 8:00 AM EDT - 3 months ago

Envoy Medical Reports on Second Quarter 2025 Results

Jul 8, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical Expands Patent Portfolio with New Issuances in the United States

Jul 1, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia

Jun 26, 2025, 8:00 AM EDT - 4 months ago

New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical

Jun 11, 2025, 8:30 AM EDT - 4 months ago

Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th

Jun 10, 2025, 8:30 AM EDT - 5 months ago

Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up

May 13, 2025, 9:15 AM EDT - 6 months ago

Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial

May 1, 2025, 4:30 PM EDT - 6 months ago

Envoy Medical Reports on First Quarter 2025 Results

Apr 22, 2025, 6:00 AM EDT - 6 months ago

EdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap Companies

Mar 31, 2025, 9:15 AM EDT - 7 months ago

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 17, 2025, 9:25 AM EDT - 8 months ago

Hearing Device Coverage Clarification Act Reintroduced in House and Senate

Mar 12, 2025, 9:00 AM EDT - 8 months ago

Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device

Mar 10, 2025, 9:00 AM EDT - 8 months ago

Envoy Medical to Participate in the 37th Annual ROTH Conference

Feb 24, 2025, 9:25 AM EST - 8 months ago

First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

Feb 14, 2025, 9:15 AM EST - 9 months ago

Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

Dec 19, 2024, 9:00 AM EST - 11 months ago

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Nov 14, 2024, 8:38 AM EST - 1 year ago

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Nov 12, 2024, 9:25 AM EST - 1 year ago

Envoy Medical's Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Nov 8, 2024, 9:25 AM EST - 1 year ago

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

Oct 23, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical to Present at the LD Micro Main Event XVII

Sep 23, 2024, 8:00 AM EDT - 1 year ago

Major Envoy Medical Investor Glen Taylor Discusses How Apple's AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company

Sep 16, 2024, 9:00 AM EDT - 1 year ago

Envoy Medical Awarded Patent for Recharge System used with Implantable Battery

Sep 12, 2024, 7:19 AM EDT - 1 year ago

Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying

HYLN SXTP

Aug 12, 2024, 8:34 AM EDT - 1 year ago

Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update

Jul 31, 2024, 8:00 AM EDT - 1 year ago

Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage

Jul 1, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical Announces Inclusion in the Russell Microcap Index

Jun 11, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling

Jun 6, 2024, 9:00 AM EDT - 1 year ago

Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index

May 19, 2024, 4:45 AM EDT - 1 year ago

Envoy Medical Is Pursuing Filling A Hearing Industry Void

May 15, 2024, 4:05 PM EDT - 1 year ago

Envoy Medical Reports First Quarter 2024 Results

Apr 3, 2024, 8:05 AM EDT - 1 year ago

Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024

Apr 2, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 12, 2024, 10:52 AM EDT - 1 year ago

Envoy Medical to Participate in the 36th Annual ROTH Conference

AllHailTrump2024 Oct. 28 at 2:03 PM

$COCH

0 · Reply

AllHailTrump2024 Oct. 27 at 8:28 PM

$COCH TRUMP back in baby. 8000 shares with a .8225 average and 4 limit buy orders pending. There is big news coming and it’s gonna make it rise RISE I say.

0 · Reply

VishalMathew Oct. 27 at 5:56 PM

$COCH Note that public warrants(COCHW) are exercisable only at 11.5 $. Unregistered warrants are exercisable at 1.3$

0 · Reply

newsfile_corp Oct. 27 at 12:01 PM

https://nfne.ws/272006 $COCH @envoymedical #Chemicals #Biotechnology #HealthCare #NASDAQ #Investing

0 · Reply

Wintermelonjuice Oct. 26 at 8:18 PM

$COCH guess co has some catalysts to support warrant conversion at $1.30. Earnings coming in around Nov 14 based on last year.

2 · Reply

BinaryLogic Oct. 25 at 7:55 PM

0 · Reply

Wintermelonjuice Oct. 25 at 4:43 PM

$COCH number of sponsors is growing?

1 · Reply

VicAge Oct. 24 at 7:41 PM

$COCH time for insiders to step up and buy shares to show confidence in the path forward.

0 · Reply

DaarT5903 Oct. 24 at 3:39 PM

$COCH $1.90 please lol

0 · Reply

Wintermelonjuice Oct. 23 at 2:09 PM

$COCH needs clarity on how the trial will be fully funded

2 · Reply

Wintermelonjuice Oct. 23 at 2:51 AM

$COCH this bill if passed will impact on Esteem hearing device's sales.

2 · Reply

biggmakk Oct. 22 at 5:27 PM

$COCH roll baby give me the money

0 · Reply

Wintermelonjuice Oct. 22 at 4:56 PM

$COCH heavily shorted so it will continue to slide but could be a big bear trap if good news comes out.

0 · Reply

biggmakk Oct. 22 at 3:22 PM

$COCH just showed up with my huge $YYAI profit lol 20000 .81 lets go

0 · Reply

Yeueehehe Oct. 22 at 10:28 AM

$COCH wtf is happening with this scam

0 · Reply

builderup Oct. 21 at 1:19 PM

$COCH made real good money with this a couple of weeks ago. Think it’s time to revisit. I’m home!

0 · Reply

AmyG28 Oct. 21 at 11:50 AM

$COCH is it ever going to move. Tired of watching it do nothing.

0 · Reply

TrackZero Oct. 20 at 4:42 PM

$COCH https://www.zacks.com/stock/news/2772337/bears-are-losing-control-over-envoy-medical-inc-coch-heres-why-its-a-buy-now

0 · Reply

Wintermelonjuice Oct. 20 at 1:01 PM

$COCH looking forward to quarterly sales figure this month as new CPT code 3 came into effect in July. If deemed medically necessary, Esteem implant could still be claimable.

1 · Reply

Wintermelonjuice Oct. 19 at 5:27 AM

$COCH through these years, the co has been focusing on the development of Acclaim which actually has its technology derived from Esteem. It's a good strategy because if they had been trying to focus on Esteem sales, it will not make the co a multi billion dollars' market cap until a reclassification by CMS is granted. They are now so close to the finish line. While they are also on the right track for Esteem with the new CPT 3 codes.

1 · Reply

Wintermelonjuice Oct. 18 at 7:29 AM

$COCH consider this has potentially first mover advantage in fully cochlear implant in the vast US market, competitors will be watching. One of the biggest competitors has market cap of about 3 billion Aussie dollars.

1 · Reply

AllHailTrump2024 Oct. 17 at 5:24 PM

$COCH it’s good that you’re basing This is as a question which means you have no idea what the heck you’re talking about!! 😂

0 · Reply

Market Cap	21.82M
Revenue (ttm)	230,000.00
Net Income (ttm)	-20.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-9,043.48%
Debt to Equity Ratio	-0.94

Volume	333,600
Avg Vol	3,838,580
Day's Range	N/A - N/A
Shares Out	25.67M
Stochastic %K	22%
Beta	2.09
Analysts	Strong Sell
Price Target	$7.83